MEGGLE Appoints Barentz as its exclusive distributor of pharmaceutical-grade lactose for the United States

AVON, OH, February 1, 2023. Barentz, a leading distributor of life science ingredients, is pleased to be appointed as the exclusive US distributor for MEGGLE GmbH & Co. – Business Unit Excipients, a world-leading manufacturer of pharmaceutical grades of lactose and co-processed excipients. MEGGLE, headquartered in Wasserburg am Inn (Germany), has been in the pharmaceutical market for more than 70 years with a broad-based lactose product portfolio. Lactose is a commonly used carrier in many pharmaceutical dosage forms.

MEGGLE, in conjunction with Barentz’ know how, exceptional customer service, regulatory support and technical sales team will bring differentiated value-added solutions to customers. With this agreement both companies will benefit from a strategic partnership that will enable them to grow in the US pharmaceutical market.

"We are very excited about this partnership with MEGGLE, a global market leader in providing high quality, differentiated lactose products. This lactose product line further compliments Barentz' current product portfolio, and MEGGLE's local manufacturing plant helps address the current supply challenges in the market," Divya Tewari, President - Pharmaceuticals at Barentz said.

"Barentz' industry knowledge, customer focus and capabilities make them the ideal partner for the distribution of our excipient portfolio in the USA," said Ruth Leinenbach, Director Business Unit Excipients at MEGGLE. "This strategic partnership is the ideal platform to supply the U.S. pharmaceutical market with our high-quality excipients from Germany and those proudly made in the USA. Our local production offers advantages especially for American customers in the area of supply security, lead times and sustainable sourcing. With Barentz at our side, we are able to meet these fundamental customer needs in the best possible way."

Anthony Litchfield, Global VP Pharma division, commented: "Barentz has had a long and successful partnership with MEGGLE in a number of European countries, and we are pleased and excited to extend our partnership to the USA."

About MEGGLE

MEGGLE Group GmbH, with its headquarters in the Bavarian city of Wasserburg (Germany), operates as a foundation for various business activities in the dairy industry and whey processing. MEGGLE has a proud history of more than 135 years in the dairy market.

The Business Unit Excipients produces pharmaceutical excipients for direct compression, granulation, capsules, sachets, powder blends and dry powder inhalers. With its broad product portfolio, intelligent innovations, and exceptional product quality, MEGGLE plays a leading role in the global pharmaceutical excipients business. With production facilities in Wasserburg (Germany) and Le Sueur, Minnesota (USA), where the requirements of the North American market are served, MEGGLE is prepared to meet customer expectations worldwide.

About Barentz

Barentz is a leading global life science ingredients distributor. The company sources branded specialty ingredients from leading manufacturers worldwide and its ingredient experts provide value-added technical support which includes pre-mixing, blending, ingredient formulation and ingredient testing from its state-of-the-art, customized formulation centers and application laboratories in EMEA, Americas and Asia-Pacific.

Established in 1953, Barentz has operations in more than 65 countries with a strong presence in Europe and North America, and a rapidly growing network in Latin America and Asia-Pacific. With a turnover of €2.5 billion, the company employs around 2,000 people worldwide and serves over 22,000 customers. For more information, visit: www.barentz-na.com

For more information, please contact:

Irena Rozic
Global Head of Marketing & Communication
irena.rozic@barentz.com +31 (0)23 567 34 56

Jami Knoth
Marketing Manager, North America
jknoth@barentz.us +1 440 937 1000